Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03677778 · ClinicalTrials.gov registry record · NA
Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT03677778: Completed NA study, sponsored by Stanford University.
NCT03677778 is a NA study that has completed, run by Stanford University. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03677778, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
One of the most frequently performed peripheral nerve blocks (the injection of local anesthetic near nerves to block sensation/ movement to a specific part of the body) is the interscalene brachial plexus block for upper extremity surgeries. This type of block can unmask underlying respiratory issues such as shortness of breath due to a well-known and typically insignificant side effect of temporary diaphragmatic paralysis. The nerve block may be able to use saline solution to wash out the local anesthetic and potentially reverse this respiratory side effect. Specifically, the goal of this study is to determine if the injection of saline through the nerve block catheter reverses blockade of the phrenic nerve supplying the diaphragm, without affecting the ability of the nerve block to provide pain control after surgery.
Interventions
- OTHER Placebo
- PROCEDURE Normal saline injected via interscalene nerve catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2018-10-22 |
| Est. Completion | 2022-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03677778
The ClinicalTrials.gov registry entry for NCT03677778 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03677778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03677778 about?
NCT03677778 is a clinical study titled "Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade". One of the most frequently performed peripheral nerve blocks (the injection of local anesthetic near nerves to block sensation/ movement to a specific part of the body) is the interscalene brachial plexus block for upper extremity surgeries. This type of block can unmask underlying respiratory issue...
What is the current status of trial NCT03677778?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2018-10-22. Estimated completion is 2022-07-07.
What interventions are being tested in trial NCT03677778?
The interventions under investigation include: Placebo (OTHER), Normal saline injected via interscalene nerve catheter (PROCEDURE).
Who is sponsoring clinical trial NCT03677778?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.